Janssen publishes positive safety and efficacy data for single-dose COVID-19 vaccine
Janssen publishes phase 3 trial data from study showing positive safety and efficacy results for its single-dose COVID-19 vaccine Vaccine shown to be 66% effective overall in preventing coronavirus in participants UK has secured 30 million doses with… read more

